Moderna could have to wait until as late as December to analyse data from its Covid-19 vaccine trial, longer than would be necessary to meet the Trump administration’s hopes of issuing an emergency approval ahead of the US election.
Moderna可能最遲要等到12月才能分析其新型冠狀病毒肺炎（COVID-19，即2019冠狀病毒病）疫苗試驗的數據，這比希望在美國大選之前發布緊急批準的特朗普政府期待的速度要慢。
您已閱讀8%（323字），剩余92%（3787字）包含更多重要信息，訂閱以繼續探索完整內容，并享受更多專屬服務。